High Sodium Intake, as Assessed by Urinary Sodium Excretion, Is Associated with Nonalcoholic Fatty Liver Disease or Sarcopenia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: We explored whether high sodium intake, assessed by urinary excretion, determines the risk of sarcopenia and nonalcoholic fatty liver disease (NAFLD). Methods: We analyzed 10,036 adult participants with normal kidney function from the Korea National Health and Nutrition Examination Survey (2008–2011). NAFLD was identified using the fatty liver index, and the muscle mass was evaluated using dual X-ray absorptiometry. The dietary sodium intake was estimated using Tanaka’s equation. Results: The mean 24-hour urinary sodium excretion was 144.2±36.1 mmol/day (corresponding to 3.3 g/day Na) in the total population. The 24-hour urinary sodium excretion showed moderate accuracy in predicting NAFLD (area under the receiver operating characteristic, 0.702; 95% confidence interval [CI], 0.692 to 0.712). A cutoff value of 99.96 mmol/day (corresponding to 2.30 g/day Na) for urinary sodium excretion in predicting NAFLD showed 76.1% sensitivity and 56.1% specificity. The results of multiple adjusted models indicated that the participants with the highest urinary sodium excretion had a significantly higher risk of NAFLD (odds ratio, 1.46; 95% CI, 1.27 to 1.66; p<0.001) and sarcopenia (odds ratio, 1.49; 95% CI, 1.28 to 1.73; p<0.001) than those with the lowest urinary sodium excretion. The association between a higher 24-hour urinary sodium excretion and NAFLD was independent of sarcopenia. Conclusions: Participants with a high sodium intake, as assessed by sodium excretion, had a substantial risk of NAFLD and sarcopenia.
Abstract
Background/Aims: We explored whether high sodium intake, assessed by urinary excretion, determines the risk of sarcopenia and nonalcoholic fatty liver disease (NAFLD). Methods: We analyzed 10,036 adult participants with normal kidney function from the Korea National Health and Nutrition Examination Survey (2008–2011). NAFLD was identified using the fatty liver index, and the muscle mass was evaluated using dual X-ray absorptiometry. The dietary sodium intake was estimated using Tanaka’s equation. Results: The mean 24-hour urinary sodium excretion was 144.2±36.1 mmol/day (corresponding to 3.3 g/day Na) in the total population. The 24-hour urinary sodium excretion showed moderate accuracy in predicting NAFLD (area under the receiver operating characteristic, 0.702; 95% confidence interval [CI], 0.692 to 0.712). A cutoff value of 99.96 mmol/day (corresponding to 2.30 g/day Na) for urinary sodium excretion in predicting NAFLD showed 76.1% sensitivity and 56.1% specificity. The results of multiple adjusted models indicated that the participants with the highest urinary sodium excretion had a significantly higher risk of NAFLD (odds ratio, 1.46; 95% CI, 1.27 to 1.66; p<0.001) and sarcopenia (odds ratio, 1.49; 95% CI, 1.28 to 1.73; p<0.001) than those with the lowest urinary sodium excretion. The association between a higher 24-hour urinary sodium excretion and NAFLD was independent of sarcopenia. Conclusions: Participants with a high sodium intake, as assessed by sodium excretion, had a substantial risk of NAFLD and sarcopenia.
참고문헌 (33)
- Younossi Z, "Global burden of NAFLD and NASH : trends, predictions, risk factors and prevention", Nat Rev Gastroenterol Hepatol, 15, pp.11~20 (2018)
- Estes C, "Modelling NAFLD disease burden in four Asian regions : 2019-2030", Aliment Pharmacol Ther, 51, pp.801~811 (2020)
- Park J, "NASH", liver fibrosis prevalence and incidence of nonliver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidities : lessons from South Korea, 2021, pp.39, 634~645
- Kim Yuna, "Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease", Gut and Liver, 16(2), pp.290~299 (2022), 거트앤리버 소화기연관학회협의회[DOI]
- Han Eugene, "Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease", Gut and Liver, 16(5), pp.786~797 (2022), 거트앤리버 소화기연관학회협의회[DOI]
- Han E, "Nonalcoholic fatty liver disease and sarcopenia are independently associated with cardiovascular risk", Am J Gastroenterol, 115, pp.584~595 (2020)
- Han E, "Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B", Aliment Pharmacol Ther, 48, pp.300~312 (2018)
- Bhanji RA, "Sarcopenia in hiding : the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis", Hepatology, 66, pp.2055~2065 (2017)
- Glass O, "Standardisation of diet and exercise in clinical trials of NAFLD-NASH : recommendations from the Liver Forum", J Hepatol, 73, pp.680~693 (2020)
- Vedovato M, "Effect of sodium intake on blood pressure and albuminuria in type 2 diabetic patients : the role of insulin resistance", Diabetologia, 47, pp.300~303 (2004)
- Huh JH, "Genderspecific association between urinary sodium excretion and body composition : analysis of the 2008-2010 Korean National Health and Nutrition Examination Surveys", Metabolism, 64, pp.837~844 (2015)
- Kweon S, "Data resource profile : the Korea National Health and Nutrition Examination Survey(KNHANES)", Int J Epidemiol, 43, pp.69~77 (2014)
- Stone NJ, "Recent National Cholesterol Education Program Adult Treatment Panel III update : adjustments and options", Am J Cardiol, 96(4A), pp.53E~59E (2005)
- Bedogni G, "The Fatty Liver Index : a simple and accurate predictor of hepatic steatosis in the general population", BMC Gastroenterol, 6, pp.33~ (2006)
- 김태년, "Sarcopenia: Definition, Epidemiology, and Pathophysiology", 대한골대사학회지, 20(1), pp.1~10 (2013), 대한골대사학회[DOI]
- Tanaka T, "A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen", J Hum Hypertens, 16, pp.97~103 (2002)
- 강명신, "Dietary Sodium Intake in People with Diabetes in Korea: The Korean National Health and Nutrition Examination Survey for 2008 to 2010", Diabetes and Metabolism Journal, 40(4), pp.290~296 (2016), 대한당뇨병학회[DOI]
- Huh JH, "High dietary sodium intake assessed by estimated 24-h urinary sodium excretion is associated with NAFLD and hepatic fibrosis", PLoS One, 10, pp.e0143222~ (2015)
- Donovan DS, "Effect of sodium intake on insulin sensitivity", Am J Physiol, 264(5 Pt 1), pp.E730~E734 (1993)
- Baudrand R, "Long-term dietary sodium restriction increases adiponectin expression and ameliorates the proinflammatory adipokine profile in obesity", Nutr Metab Cardiovasc Dis, 24, pp.34~41 (2014)
- Pizarro M, "Beneficial effects of mineralocorticoid receptor blockade in experimental nonalcoholic steatohepatitis", Liver Int, 35, pp.2129~2138 (2015)
- Lenda DM, "Effect of a high-salt diet on oxidant enzyme activity in skeletal muscle microcirculation", Am J Physiol Heart Circ Physiol, 282, pp.H395~H402 (2002)
- Liu Y, "Response of resistance arteries to reduced PO2 and vasodilators during hypertension and elevated salt intake", Am J Physiol, 273(2Pt 2), pp.H869~H877 (1997)
- Lanaspa MA, "High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism", Proc Natl Acad Sci U S A, 115, pp.3138~3143 (2018)
- Kohara K, "Leptin in sarcopenic visceral obesity : possible link between adipocytes and myocytes", PLoS One, 6, pp.e24633~ (2011)
- Kim D, "Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States", Liver Int, 41, pp.1832~1840 (2021)
- Nam GE, "Association between 24-h urinary sodium excretion and obesity in Korean adults : a multicenter study", Nutrition, 41, pp.113~119 (2017)
- Park HK, "Progress on sodium reduction in South Korea", BMJ Glob Health, 5, pp.e002028~ (2020)
- "Guideline: sodium intake for adults and children" (2012)[URL]
- Costa AP, "High sodium intake adversely affects oxidative-inflammatory response, cardiac remodelling and mortality after myocardial infarction", Atherosclerosis, 222, pp.284~291 (2012)
- He FJ, "How far should salt intake be reduced?", Hypertension, 42, pp.1093~1099 (2003)
- Paik JM, "Mortality related to nonalcoholic fatty liver disease is increasing in the United States", Hepatol Commun, 3, pp.1459~1471 (2019)
- Han E, "Association between dietary acid load and the risk of cardiovascular disease : nationwide surveys(KNHANES 2008-2011)", Cardiovasc Diabetol, 15, pp.122~ (2016)